Table 4 Patient reported outcomes
Study success | PPGP | No PPGP | Men | |||
|---|---|---|---|---|---|---|
N | Successful (%) | N | Successful (%) | N | Successful (%) | |
Success at 6 months | 19 | 18 (94.7 %) | 100 | 78 (78.0 %) | 50 | 40 (80.0 %) |
Success at 12 months | 17 | 13 (76.5 %) | 95 | 74 (77.9 %) | 46 | 38 (82.6 %) |
PPGP | No PPGP | Men | ||||
|---|---|---|---|---|---|---|
N | Mean (SD) | N | Mean (SD) | N | Mean (SD) | |
VAS SI pain | ||||||
Baseline | 20 | 81.9 (10.0) | 100 | 79.9 (13.3) | 52 | 78.9 (12.9) |
1 month | 20 | 31.6 (25.3) | 98 | 38.9 (26.7) | 50 | 35.2 (26.2) |
3 months | 20 | 36.0 (24.4) | 99 | 29.6 (26.3) | 50 | 30.6 (26.0) |
6 months | 19 | 21.3 (17.6) | 100 | 31.5 (27.0) | 50 | 30.2 (28.0) |
12 months | 17 | 31.4 (30.9) | 94 | 32.7 (28.5) | 45 | 25.0 (24.0) |
12 month change | −51.1 (32.6) | −46.9 (29.9) | −52.9 (27.5) | |||
>20 mm decrease | 18 | 94.7 % | 78 | 78 % | 40 | 80 % |
Change from baseline (p = .3708)§ | p < .0001* | p < .0001 | p < .0001 | |||
ODI | ||||||
Baseline | 20 | 52.2 (12.7) | 100 | 55.0 (11.2) | 52 | 56.7 (11.5) |
1 months | 20 | 43.0 (16.9) | 98 | 44.5 (16.9) | 50 | 38.8 (18.3) |
3 months | 20 | 37.6 (17.3) | 99 | 33.1 (17.8) | 50 | 33.8 (21.2) |
6 months | 19 | 30.4 (20.0) | 100 | 31.0 (18.7) | 50 | 36.4 (21.4) |
12 months | 17 | 32.8 (21.4) | 95 | 30.8 (19.1) | 46 | 31.9 (18.9) |
12 month change | −20.6 (26.0) | −24.1 (19.5) | −24.6 (21.0) | |||
Change from baseline (p = .3100) | p < .0001 | p < .0001 | p < .0001 | |||
SF-36 PCS | ||||||
Baseline | 20 | 32.0 (5.6) | 98 | 31.1 (5.6) | 51 | 32.7 (5.5) |
6 months | 19 | 40.0 (11.1) | 100 | 40.5 (9.2) | 49 | 39.8 (10.1) |
12 months | 17 | 41.6 (10.8) | 91 | 40.0 (9.6) | 46 | 40.5 (8.9) |
12 month change | 10.4 (10.1) | 8.7 (9.9) | 8.1 (9.8) | |||
Change from baseline (p = .3623) | p < .0001 | p < .0001 | p < .0001 | |||
SF-36 MCS | ||||||
Baseline | 20 | 42.2 (12.4) | 98 | 37.7 (11.6) | 51 | 38.6 (10.3) |
6 months | 19 | 49.7 (9.6) | 100 | 48.8 (10.8) | 49 | 45.1 (13.2) |
12 months | 17 | 49.0 (10.8) | 91 | 47.7 (12.9) | 46 | 48.0 (12.1) |
12 month change | 7.2 (12.0) | 10.2 (11.9) | 8.2 (11.2) | |||
Change from baseline (p = .1313) | p < .0001 | p < .0001 | p < .0001 | |||
EQ-5D TTO | ||||||
Baseline | 20 | 0.42 (0.14) | 97 | 0.43 (0.18) | 52 | 0.45 (0.19) |
6 months | 19 | 0.72 (0.23) | 98 | 0.70 (0.19) | 50 | 0.64 (0.25) |
12 months | 17 | 0.72 (0.21) | 92 | 0.70 (0.20) | 46 | 0.72 (0.19) |
12 month change | 0.31 (0.29) | 0.27 (0.24) | 0.26 (0.24) | |||
Change from baseline (p = .0446) | p < .0001 | p < .0001 | p < .0001 | |||
PPGP | No PPGP | Men | ||||
|---|---|---|---|---|---|---|
N | ||||||
Satisfaction at 12 months (p = .1252) | ||||||
Very or somewhat satisfied | 17 | 100 % | 79 | 84.0 % | 42 | 91.3 % |
No | 0 | 0 % | 15 | 16.0 % | 4 | 8.7 % |
Would have surgery again (p = .6503) | ||||||
Might or definitely yes | 16 | 94.1 % | 84 | 89.4 % | 43 | 93.5% |
No | 1 | 5.9 % | 10 | 10.6 % | 3 | 6.5 % |